CONy 2020 | Treating MS: new therapies and COVID-19

Abhijit Chaudhuri, DM, MD, PhD, FACP, FRCP, FEAN, Queen’s Hospital, Romford, UK, discusses recent innovations in multiple sclerosis (MS). In light of the pandemic, therapeutic strategies have been changed to limit hospital visits and enable high efficacy home treatment. There have also been developments in monoclonal antibodies that do not require intravenous administration, such as ofatumumab. Additionally, for progressive forms of MS, ocrelizumab is now an option. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.